Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.39B 12.9B | Sales 2025 * | 9.4B 12.92B | Capitalization | 3.19B 4.38B |
---|---|---|---|---|---|
Net income 2024 * | 218M 300M | Net income 2025 * | 416M 572M | EV / Sales 2024 * | 2.46 x |
Net Debt 2024 * | 19.91B 27.36B | Net Debt 2025 * | 18.33B 25.19B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
13.9
x | P/E ratio 2025 * |
7.76
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.69% | 147B | |
-6.63% | 144B |